Subsequent Event (Details) - Aug. 11, 2015 - Subsequent Event [Member] - Merck [Member] $ / ingredient in Millions, $ in Millions	USD ($) $ / ingredient
Subsequent Event [Line Items]
Contingent payment	$ 18.0
Proceeds from license fees received	5.0
Contingent payment, completion of milestones and agreement	$ 13.0
Minimum [Member]
Subsequent Event [Line Items]
Term of milestone agreement	15 months
Maximum [Member]
Subsequent Event [Line Items]
Term of milestone agreement	24 months
Contingent payment, per active pharmaceutical ingredient \| $ / ingredient	15

Revenue Recognition, Milestone Method, Contingent Payment

No definition available.

Name:	cdxs_RevenueRecognitionMilestoneMethodContingentPayment
Namespace Prefix:	cdxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue Recognition, Milestone Method, Contingent Payment, Completion of Milestones and Agreement

+ References

No definition available.

+ Details

Name:	cdxs_RevenueRecognitionMilestoneMethodContingentPaymentCompletionofMilestonesandAgreement
Namespace Prefix:	cdxs_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Revenue Recognition, Milestone Method, Contingent Payment, Per Active Pharmaceutical Ingredient

+ References

No definition available.

+ Details

Name:	cdxs_RevenueRecognitionMilestoneMethodContingentPaymentPerActivePharmaceuticalIngredient
Namespace Prefix:	cdxs_
Data Type:	us-types:perUnitItemType
Balance Type:	na
Period Type:	duration

- Definition

Revenue Recognition, Milestone Method, Term of Milestone Agreement

+ References

No definition available.

+ Details

Name:	cdxs_RevenueRecognitionMilestoneMethodTermofMilestoneAgreement
Namespace Prefix:	cdxs_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Cash received from licensees for license fees during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cdxs_MerckMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: